- About
About
- Patients
The Clinical and Diagnostic Department of Hematology and Hemostasis Disorders of the NMRC for Hematology of the Ministry of Health of the Russian Federation is conducting a clinical trial of the ANB-002-1/ SAFRAN gene therapy drug in patients with severe hemophilia B. The drug was developed by the Russian biotechnology company BIOCAD.
11-13th of April 2024, Moscow will host the Joint VII Congress of Hematologists of Russia and the IV Congress of Transfusiologists of Russia.
Addressing the participants of the conference "Tatiana's Day – Elements of Artificial Intelligence in Modern Hematology,” Candidate of Technical Sciences, Head of the Information and Analytics Division of the NMRC for Hematology of the Ministry of Health of the Russian Federation, Sergey M. Kulikov noted that the purpose of his report is to protect researchers from false expectations of a miracle.
A group of experts from eight Central European countries, including Russia, has published a systematic review of 478 unique articles on the use of thrombopoietin receptor agonists in adults with immune thrombocytopenia. The review is published in the journal Annals of Hematology.
The Nanophore 5 genetic analyzer was produced by the Russian scientific production company Syntol in cooperation with the Institute of Analytical Instrumentation of the Russian Academy of Sciences (St. Petersburg) and the Experimental Plant of Scientific Instrumentation of the Russian Academy of Sciences (Chernogolovka). The employees of the Laboratory of Genetic Engineering note the accuracy and reliability of the measuring instrument.
The NMRC for Hematology of the Ministry of Health of Russia has expanded the registration certificate for new dosages of the drug "Agemfil A.” Industrial production of the drug in dosages of 500 IU and 1000 IU has begun.
Each person has their own story. Often, very difficult patients who could not be helped in the regions travel for an appointment. What or who motivates doctors to see new patients every morning? The responsible individual is the head of the Division of Diagnostics and Treatment of Hematological Diseases, hematologist, Alina Kohno.
The story about how difficult trials can be treated with humor and interest. Thanks to the doctors of the NMRC for Hematology, Julia Shatskaya was cured of lymphoma, wrote a song, shot a music video and changed her life paradigm to become a doctor.
On December 20th, the International Multimedia Press Center "Russia Today" hosted a solemn ceremony of awarding participants in the All-Russian Action-Competition "The Donor’s Code. Mentoring." The year 2023 was declared the Year of the Teacher and Mentor by Decree of Russian President, Vladimir Putin.
08.12.2023Let Me Find a Donor TooAnastasia from Makeyevka is 27 years old. When she was diagnosed with acute lymphoblastic leukemia, it seemed that there was no way out. Anastasia is currently undergoing her first course of chemotherapy at the NMRC for Hematology of the Ministry of Health of Russia and believes that she will win.
A large-scale campaign in support of bone marrow donation #DavaiVstupai ended on November 10 in Arkhangelsk.
The story of a cancer patient's struggle for the happiness of becoming a mother. In 2018, at the 16th week of pregnancy, Ruslana was diagnosed with primary mediastinal large B-cell lymphoma. She has walked a difficult path, but now that is all behind her. Today, thanks to the doctors of the NMRC for Hematology of the Ministry of Health of Russia, she is raising her son and helping to save the lives of people faced with oncology.
- Patients
